Investor Overview

Who is Organovo?
  • We participate in attractive and growing markets with critical unmet needs
  • We benefit from favorable competitive dynamics and a first mover advantage
  • We’re a technology leader with a strong IP portfolio
  • We’re leveraging our technology platform to build a robust product and service platform across the high-value drug profiling and therapeutic tissues markets
2017 Annual Report Investor Fact Sheet Investor Presentation

Stock Information
ONVO (Common Stock)
ExchangeNASDAQ (US Dollar)
Change (%) + 0.05 (3.11%)
Data provided by Nasdaq. Minimum 15 minutes delayed.
Stock chart for: ONVO.O.  Currently trading at $1.66 with a 52 week high of $4.08 and a 52 week low of $1.32.
Recent Investor News
Organovo Presents New Preclinical Data on 3D Bioprinted Human Liver Tissues for the Treatment of Inborn Errors of Metabolism at The Liver Meeting® 2017 (AASLD)
Organovo Announces Release Date for Fiscal Second-Quarter 2018 Financial Results
Investor Events
Thursday, November 9, 2017 5:00 p.m. ET
Q2 2018 Organovo Holdings Inc Earnings Conference Call
Featured Reports
2017 Annual Report
2017 Proxy Statement
Latest Tweets
Print Page Print Page | E-mail Page Email Page | RSS Feeds RSS Feeds | IR Contacts Investor Contacts | Financial Tear Sheet Financial Tear Sheet